Targeting the interleukin-5 pathway in EGPA: evidence, uncertainties and opportunities
Alvise Berti, Fabiola Atzeni, Lorenzo Dagna, Stefano Del Giacco, Giacomo Emmi, Carlo Salvarani, Augusto Vaglio
Topics & Concepts
MepolizumabMedicineGranulomatosis with polyangiitisBenralizumabAsthmaEosinophilicImmunologyInterleukin 5EosinophilDiseaseInternal medicineInterleukinVasculitisPathologyCytokineVasculitis and related conditionsInterstitial Lung Diseases and Idiopathic Pulmonary FibrosisUrticaria and Related Conditions